H.R. 5461: Special Diabetes Program Reauthorization Act of 2025
This bill, known as the Special Diabetes Program Reauthorization Act of 2025, aims to provide continued financial support for diabetes programs, specifically focusing on Type I diabetes. Here’s a breakdown of its key components:
Funding Extension
The bill proposes an amendment to existing law regarding the Special Diabetes Programs, which are crucial for research and treatment of Type I diabetes. The main points include:
- The bill seeks to extend the funding for these programs by allocating $160 million annually for each fiscal year from 2026 through 2030.
- This funding will stay available until it is fully utilized, ensuring sustained financial resources for diabetes initiatives.
Impact on Diabetes Research and Treatment
The funding provided through this bill is intended to support various activities, which might include:
- Research aimed at improving treatment options for individuals with Type I diabetes.
- Development of better management techniques and potential cures for the disease.
- Efforts to increase awareness and education surrounding diabetes, specifically focusing on Type I diabetes challenges.
Legislative Process
The bill was introduced by Ms. DeGette, along with co-sponsors Mr. Bilirakis and Mr. Ruiz, and is currently under consideration in the House Committee on Energy and Commerce.
Conclusion
This legislation represents a commitment to addressing the ongoing needs of individuals with Type I diabetes through sustained funding and support for relevant programs.
Relevant Companies
- MDLZ - Mondelez International, which produces diabetes-friendly food options as part of its product line.
- ABBV - AbbVie, involved in the development of medications for diabetes management.
- UNH - UnitedHealth Group, which may see impacts on healthcare coverage and treatments for diabetes patients.
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
31 bill sponsors
-
TrackDiana DeGette
Sponsor
-
TrackTroy Balderson
Co-Sponsor
-
TrackNanette Diaz Barragán
Co-Sponsor
-
TrackGus M. Bilirakis
Co-Sponsor
-
TrackEmanuel Cleaver
Co-Sponsor
-
TrackAngie Craig
Co-Sponsor
-
TrackSharice Davids
Co-Sponsor
-
TrackDonald G. Davis
Co-Sponsor
-
TrackLloyd Doggett
Co-Sponsor
-
TrackMike Flood
Co-Sponsor
-
TrackDaniel S. Goldman
Co-Sponsor
-
TrackPramila Jayapal
Co-Sponsor
-
TrackDavid P. Joyce
Co-Sponsor
-
TrackSarah McBride
Co-Sponsor
-
TrackGwen Moore
Co-Sponsor
-
TrackJerrold Nadler
Co-Sponsor
-
TrackMark Pocan
Co-Sponsor
-
TrackEmily Randall
Co-Sponsor
-
TrackJamie Raskin
Co-Sponsor
-
TrackJosh Riley
Co-Sponsor
-
TrackRaul Ruiz
Co-Sponsor
-
TrackRobert C. "Bobby" Scott
Co-Sponsor
-
TrackDarren Soto
Co-Sponsor
-
TrackClaudia Tenney
Co-Sponsor
-
TrackShri Thanedar
Co-Sponsor
-
TrackBennie G. Thompson
Co-Sponsor
-
TrackRashida Tlaib
Co-Sponsor
-
TrackDerek Tran
Co-Sponsor
-
TrackLauren Underwood
Co-Sponsor
-
TrackMaxine Waters
Co-Sponsor
-
TrackJoe Wilson
Co-Sponsor
Actions
2 actions
| Date | Action |
|---|---|
| Sep. 18, 2025 | Introduced in House |
| Sep. 18, 2025 | Referred to the House Committee on Energy and Commerce. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
